Literature DB >> 11488522

Fendiline, an anti-anginal drug, increases intracellular Ca2+ in PC3 human prostate cancer cells.

C R Jan1, K C Lee, K J Chou, J S Cheng, J L Wang, Y K Lo, H T Chang, K Y Tang, C C Yu, J K Huang.   

Abstract

BACKGROUND: The effects of the anti-anginal drug fendiline on intracellular Ca2+ concentrations ([Ca2+]i) in human PC3 prostate cancer cells were examined.
METHODS: [Ca2+]i was measured using the fluorescent dye fura-2.
RESULTS: Fendiline (0.5-100 microM) increased [Ca2+]i in a concentration-dependent manner. Ca2+ removal partly inhibited the Ca2+ signals. In Ca2+-free medium, pretreatment with 100 microM fendiline inhibited most of the [Ca2+]i increase induced by 1 microM thapsigargin (an endoplasmic reticulum Ca2+ pump inhibitor), and pretreatment with thapsigargin abolished the fendiline-induced [Ca2+]i increases. Adding 3 mM Ca2+ increased [Ca2+]i in cells pretreated with 0.5-200 microM fendiline in Ca2+-free medium. Pretreatment with 1 microM U73122 to block the formation of inositol-1.4.5-trisphosphate (IP3) did not alter fendiline-induced internal Ca2+ release.
CONCLUSIONS: The anti-anginal drug fendiline induced internal Ca2+ release and external Ca2+ entry. Because prolonged increases in [Ca2+]i may lead to cell injury and death, the long-term effect of fendiline on the function of prostate cancer cells should be investigated.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11488522     DOI: 10.1007/s002800000262

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  4 in total

Review 1.  Clinical potential of GABAB receptor modulators.

Authors:  Jennifer Ong; David I B Kerr
Journal:  CNS Drug Rev       Date:  2005

2.  Fendiline inhibits K-Ras plasma membrane localization and blocks K-Ras signal transmission.

Authors:  Dharini van der Hoeven; Kwang-jin Cho; Xiaoping Ma; Sravanthi Chigurupati; Robert G Parton; John F Hancock
Journal:  Mol Cell Biol       Date:  2012-11-05       Impact factor: 4.272

Review 3.  Antihypertensive drugs use and the risk of prostate cancer: a meta-analysis of 21 observational studies.

Authors:  Liang Cao; Sha Zhang; Cheng-Ming Jia; Wei He; Lei-Tao Wu; Ying-Qi Li; Wen Wang; Zhe Li; Jing Ma
Journal:  BMC Urol       Date:  2018-03-07       Impact factor: 2.264

4.  Efficacy of a Three Drug-Based Therapy for Neuroblastoma in Mice.

Authors:  Patrizia Garbati; Raffaella Barbieri; Matilde Calderoni; Francesca Baldini; Mario Nizzari; Paola Modesto; Tullio Florio; Aldo Pagano
Journal:  Int J Mol Sci       Date:  2021-06-23       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.